HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer JAMA Oncology, February 13, 2020

Hot Topics of the Day|PHGKB


Last Posted: Feb 14, 2020

---

• HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
  JAMA Oncology, February 13, 2020
• Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.
  González-Billalabeitia Enrique et al. Prostate cancer and prostatic diseases 2019 22(2) 195-205
• The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial.
  Fredsøe Jacob et al. PLoS medicine 2020 Feb 17(2) e1003033
• What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
  Greenberg Samantha et al. The Prostate 2020 Feb
• Genomics to personalize care of prostate cancer.
  Connors Laurie M et al. Journal of the American Association of Nurse Practitioners 2020 Feb 32(2) 106-108
• Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care.
  Lee Siang Ing et al. Journal of community genetics 2020 Jan
• Genetic Testing in Prostate Cancer.
  Sokolova Alexandra O et al. Current oncology reports 2020 Jan 22(1) 5
• Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.
  Schweizer Michael T et al. The Prostate 2019 79(7) 701-708
• Circulating cell-free DNA: Translating prostate cancer genomics into clinical care.
  Gasi Tandefelt Delila et al. Molecular aspects of medicine 2020 Jan 100837
• Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
  Ström Peter et al. The Lancet. Oncology 2020 Jan

more